The ORVAC trial protocol: A phase IV, double-blind, randomised, placebo-controlled clinical trial of a third scheduled dose of Rotarix rotavirus vaccine in Australian Indigenous infants to improve protection against gastroenteritis
Bianca Fleur Middleton, Mark A. Jones, Claire S. Waddington, Margaret Danchin, Carly McCallum, Sarah Gallagher, Amanda Jane Leach, Ross Andrews, Carl Kirkwood, Nigel Cunliffe, Jonathan Carapetis, Julie A. Marsh, Tom Snelling
Research output: Contribution to journal › Article › peer-review
10
Link opens in a new tab
Citations
(Scopus)
110
Downloads
(Pure)